NHS National Generic Pharmaceuticals- Transition 2021_1
key details
| Value | £8,858,050 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 7 Jan 2021 |
| Contract start | 15 Apr 2021 |
| Contract end | 30 Jun 2022 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-f12a776d-f32e-4538-afa1-a60bba14ba3e |
Awards (20)
This procurement was awarded to 20 suppliers. Values shown are per-award; the notice total is £8,858,050.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd shared | £8,858,050 | 3 Mar 2021 | active |
| Amarox Limited shared | £8,858,050 | 3 Mar 2021 | active |
| Ascend Laboratories UK Ltd shared | £8,858,050 | 3 Mar 2021 | active |
| Aspen Pharma Ireland Limited shared | £8,858,050 | 3 Mar 2021 | active |
| Aspire Pharma Limited shared | £8,858,050 | 3 Mar 2021 | active |
| Aventis Pharma ltd t/a Sanofi shared | £8,858,050 | 3 Mar 2021 | active |
| Brown & Burk UK Ltd shared | £8,858,050 | 3 Mar 2021 | active |
| Day Lewis Medical Ltd shared | £8,858,050 | 3 Mar 2021 | active |
| Dr.Reddy's Laboratories (UK) Limited shared | £8,858,050 | 3 Mar 2021 | active |
| Kent Pharma Ltd shared | £8,858,050 | 3 Mar 2021 | active |
| Martindale Pharma shared | £8,858,050 | 3 Mar 2021 | active |
| medac Pharma LLP shared | £8,858,050 | 3 Mar 2021 | active |
| Morningside Pharmaeuticals shared | £8,858,050 | 3 Mar 2021 | active |
| Panpharma UK Limited shared | £8,858,050 | 3 Mar 2021 | active |
| Pfizer Ltd shared | £8,858,050 | 3 Mar 2021 | active |
| Ranbaxy UK shared | £8,858,050 | 3 Mar 2021 | active |
| Selective Supplies Ltd. shared | £8,858,050 | 3 Mar 2021 | active |
| Teva UK Limited shared | £8,858,050 | 3 Mar 2021 | active |
| Thornton and Ross Ltd shared | £8,858,050 | 3 Mar 2021 | active |
| Tillomed Laboratories ltd shared | £8,858,050 | 3 Mar 2021 | active |
description
NHS National PharmaceuticalsTransition 2021_1 Offer referencenumber: CM/PHG/20/5629 Period offramework agreement: the totalmaximum duration of the frameworkagreement to be no more than 29months (14.5 months plus options toextend (at the Authority's solediscretion) for up to a further 14.5months) Potential Periods of call-offsunder the framework agreementTransition and 33 % Products:
CESW 15 April 2021 to 30 September2021 (5.5 months);
LSNE 15 April 2021 to 28 February2022 (10.5 months);
NWLN 15 April 2021 to 30 June 2022(14.5 months);
- % Products (All Regions): 15 April2021 to 28 February 2022 (10.5months).
documents
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kEd4/XwQbtBnchN4R5dAjl2yoRF6_6wX2EYfkLzl09RI2wZs , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kEd5/o7S4twyLM9yyDqAh5CQZp_89yojsh0ddghuG3SsmKko , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kEd6/O0UiAHKXxHLeWlkBQOtO1QQ0L7sc5eBtxMJK.pnWWZ4 , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kEd7/0z5FL5528ba6qJooPvRYv.7Y_V8znkQf8y_8jStaBo8 , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kEd8/7o8criMkxQNM17bZE5E88pOvdtedxHTuzBoFsYHY.kQ , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kEd9/651VR83iBzfyQzDnidyYIpOkBc1Cs7H5BBNDgKLJBpQ , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kEdA/gh.ZFum73oyt6PDr4w76cBtM0tHiZQr5N1w7tlW8mWk , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kEdB/kxbst.ECxCTxEx8HDsc86tx_UK21BlJLbzhJcudKOqc , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kEdC/4q4MWl01zJ_l8H0k2Z3PkD3SnQZspXIfDMv3J1L382w , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kEdD/hs6bnrtnyK8yV.2.TIL0F5Sr4L0mHqmzbioGBCK..9I , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kEdE/0V9GNNVIZGvntn3ZpAwfd5LRF7fC1uJB9.ACx8J1cYU , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kEdF/qH6nxplhcVOAnIP00XDRnoYnN7EYhs32QRZ_d4uGvio , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kEdG/tBN8kiGHZLmvyiOMwNn7Oaxlus.qlf40vzvj1l1eikw , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kEdJ/jxNjGVBIKli0unQwl8o8RxuVuiVZgTmIAvQKA4aKkRA , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kEdO/iHeZrgoIplrn3wr2VmrPhdTnczEnqRHPmGinOpkPBpc , Link
- https://www.contractsfinder.service.gov.uk/Notice/0a8d82f3-fb44-40ce-9394-71f94a74d82d , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/a5ca9c4f-dfac-4b9e-9fa3-5fe8d99d218f , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/c48608f4-be0d-4191-abe9-6a46ebf073f7 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 7 Dec 2020 | Tender (tender) | · | 0a8d82f3-fb44-40ce-9394-71f94a74d82d-398528 |
| 30 Apr 2021 | Award update (awardUpdate) | · | 72ba4c81-046c-4956-9612-28781828c842-433029 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.